Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
The deadline for the annual research grants, which support coagulation research, is November 14. Find out what makes a winnin…
Eke and Sterre talk about life with hemophilia, a bleeding disorder mostly associated with men. They’re advocating for more a…
November is Alpha-1 Awareness Month. Learn more about Alpha 1 Antitrypsin Deficiency, a rare genetic condition caused by the …
Excessive packaging is an unnecessary burden on the environment. In Australia, CSL is now able to use less for boxed injectab…
CSL is among the winners of this year’s prizes for pharmaceutical products that improve the human condition. The Prix Galien …
A panel at the recent event, presented by the National Organization for Rare Disorders, discussed next-level collaboration an…
Earlier this month, CSL hosted a weekend of baseball, basketball, golf and swimming for kids in the bleeding disorders commun…
Project ECHO, a partnership with the Immune Deficiency Foundation, will educate health care providers, including school nurse…
The global biotech company has entered a renewable-linked power purchase agreement in Australia.
Americas
Asia Pacific
Middle East
Europe
